Core clinical engineering and protocols for Targeted Payload Release.
Conventional intravenous chemotherapy distributes indiscriminately throughout the human body, damaging hair follicles, bone marrow, and gastrointestinal mucosa, forcing oncologists to limit drug doses below optimal therapeutic efficacy.
HealthNanorobots incorporates biocompatible polymer shells linked via pH-sensitive covalent bonds. While the nanorobots circulate harmlessly in neutral bloodstream (pH 7.4), encountering the acidic microenvironment of solid tumors hydrolyzes the linkers, releasing 100% of the cytotoxic agent directly into the cancer cells.